Potential Hepatoprotective Effects of Adenosine Triphosphate Against Olaparib-Induced Oxidative Liver Injury: An Experimental Rat Model
Ahmed Ramiz Baykan, Serkan Cerrah, Emine Kartal Baykan, Serdar Tanas, Bulent Yavuzer, Gulce Naz Yazici, Mehmet Kuzucu, Durdu Altuner, Halis Suleyman · 2026
Read Potential Hepatoprotective Effects of Adenosine Triphosphate Against Olaparib-Induced Oxidative Liver Injury: An Experimental Rat Model by Ahmed Ramiz Baykan, Serkan Cerrah, Emine Kartal Baykan, Serdar Tanas, Bulent Yavuzer, Gulce Naz Yazici, Mehmet Kuzucu, Durdu Altuner, Halis Suleyman (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13311218.txt.
Description
Ahmed Ramiz Baykan and co-authors in 2026 report a rat study on whether ATP can shield the liver from harm caused by olaparib, a cancer drug. The drug can injure liver cells through oxidative stress.
Twenty-four male rats were split into four groups: healthy, drug only, drug plus ATP, and drug plus melatonin, over 14 days. Liver tissue was tested for damage and defense markers, and blood tests checked liver enzymes. The design lets the team weigh ATP against a known protective agent. Findings could point to a simple add-on that guards the liver during cancer treatment.
Catalog record
| CREATOR | Ahmed Ramiz Baykan, Serkan Cerrah, Emine Kartal Baykan, Serdar Tanas, Bulent Yavuzer, Gulce Naz Yazici, Mehmet Kuzucu, Durdu Altuner, Halis Suleyman |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 56463 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |